Despite decades of R&D effort, almost all biopharmaceuticals remain well beyond the reach of oral formulation technology. Today, these medicines are usually administered in a healthcare setting rather ...

Last year, the biotechnology industry celebrated the twentieth anniversary of the approval of the first true product of modern biotechnology—recombinant insulin (Humulin; Genentech, S. San Francisco, ...

Pfizer announced it will invest $465 million to build a new Modular Aseptic Processing Facility in Kalamazoo County, MI. The 400,000-square-foot facility, which will produce critical life-saving ...

Multifidelity optimization can inform decision-making during process development and reduce the number of experiments ...

From life-saving vaccines to advanced cancer therapies, biopharmaceuticals are quietly transforming modern medicine. Made ...

Since 2003, BioPlan Associates, Inc. has published an extensive annual survey of bioprocessing professionals. Since the first survey, which was started in collaboration with the American Society for ...

Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals. The current biopharmaceutical industry is estimated at more than $400 billion/year revenue and continues to ...

The accurate characterization of proteins and other compounds is a major determinant of success in biopharmaceutical development. Molecular insights obtained by analytical technologies guide the ...